Table 3.
Comparison between co-expressed genes and not co-expressed genes in CEXlists.
| cp-value threshold | 0.05 | 0.01 | 0.005 | 0.001 |
|---|---|---|---|---|
| ACTA1 | 1.601 | 1.168 | 1.187 | 2.215 |
| DES | 1.366* | 1.285 | 0.659 | 0.000 |
| SPG7_HUMAN | 2.078* | 1.957* | 1.846* | 2.078* |
| SMAD2 | 1.877* | 1.414* | 1.297 | 1.361 |
| SMAD3 | 1.363* | 1.354 | 1.206 | 0.000 |
| ADAM12 | 0.803 | 0.965 | 1.003 | 0.777 |
| C9orf3 | 1.662* | 1.400* | 1.443* | 1.381 |
| APLP1 | 0.879 | 1.228 | 1.380 | 0.525 |
| WISP2 | 1.311 | 0.559 | 0.000 | 0.000 |
| SLC9A3R2 | 1.079 | 1.083 | 1.380 | 2.673 |
| MNT | 1.789* | 1.893* | 1.426 | 0.855 |
| ALDOA_HUMAN | 1.008 | 0.986 | 0.759 | 0.000 |
| DEFA3 | 0.974 | 1.576 | 0.000 | 0.000 |
| AURKA | 1.274 | 1.247 | 0.687 | 1.145 |
| AURKB | 1.999* | 2.263* | 2.249* | 2.353* |
| FSHR | 0.000 | 0.000 | 0.000 | 0.000 |
| LRRTM1 | 0.871 | 0.000 | 0.000 | 0.000 |
| AURKC_HUMAN | 0.556* | 0.515 | 1.180 | 0.000 |
| MRGPRF | 1.559 | 1.697 | 1.300 | 0.000 |
| Q658L9_HUMAN | 0.000 | 0.000 | 0.000 | 0.000 |
| DUSP12 | 1.446* | 2.139* | 1.555 | 1.993 |
| EEF1D | 1.649* | 1.515* | 1.634* | 1.348 |
| ALB | 1.953* | 1.877* | 1.769* | 0.972 |
| C6orf62 | 1.930* | 1.756* | 1.926* | 1.626 |
| CLK3 | 0.759* | 0.970 | 0.558 | 1.953 |
For four cp-value thresholds, t, the table compares Gemma genes present in CEXlists (cp-value <t) and Gemma genes not present in CEXlists (cp-value >t). For genes present or not in CEXlists, the ratio of genes in Gemma per gene is computed. The final value in the Table is the ratio of the result obtained for a CEXlist and the genes out of it. Thus, a value above one indicates an enrichment of co-expressed genes in a CEXlist. Fisher tests were used to compare the distribution of Gemma genes in and out of CEXlists, a "*" indicates a distribution significantly different (p < 0.05).